Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_assertion type Assertion NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_head.
- NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_assertion wasGeneratedBy ECO_0000203 NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_provenance.
- NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_assertion wasDerivedFrom befree-20150227 NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_provenance.
- NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_assertion SIO_000772 23554355 NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_provenance.
- NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_assertion evidence source_evidence_literature NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_provenance.
- NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_assertion description "[GPER1 expression was analyzed by immunohistochemistry in breast tumors from 273 pre- and postmenopausal stage II patients, all treated with adjuvant tamoxifen for 2 years (cohort I) and from 208 premenopausal lymph node-negative patients, of which 87% were not subjected to any adjuvant systemic treatment (cohort II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432856.RAlyL99lvlygYVhhMdk1eAu0DvUlLEaOmFdp3bG81dhmU130_provenance.